Please vote for our app, so more patients can benefit!

22 Jun 2017, 12:31 p.m.

Blood Quest app

Our app Blood Quest is a finalist in two categories of the AbilityNet Tech4Good Awards, which recognise organisations and individuals using technology for real, tangible good. “With the help of the right people, technology can really help change people’s lives,” said Mark Walker, the Tech4Good Awards' Organiser.

Blood Quest is a free, beautifully illustrated iPad app we created to inform, entertain and distract patients while they’re having their blood taken, helping them to prepare for the test and alleviating anxiety. They can play the ‘quest’ game with different levels to complete, and answer quizzes about animals and their hearts. Each level lasts the length of an average blood test, and is designed to occupy the young person specifically during the procedure.

As well as the Digital Health award, which is voted for by judges, we have been nominated for the People’s Award, decided by the public, which is where YOU can help!

We need to harness as much support as possible via our webpage and hashtag before voting closes on at 5pm on Friday 7 July. Voting is a free opportunity to spread the word about the app far and wide, so more patients can benefit from using it.

To vote, please retweet this tweet, or post your own message on Twitter or Instagram and include our unique hashtag #T4GBloodQuest. You can also vote on the Tech4Good site. Thanks for your support!

Vote for us on the Tech4Good site!

Vote for us on the Tech4Good site!

Surgeon who saved children’s sight surprised by patients, family and colleagues

Professor Chris Lloyd, consultant ophthalmic surgeon and paediatric ophthalmologist, was given a surprise to remember as a part of the BBC The One Show’s ‘One Big Thank You’.

Gentler treatment eliminates early deaths for children with relapsed leukaemia

A groundbreaking national study led by clinicians at Great Ormond Street Hospital (GOSH) has shown that children and young people with relapsed acute lymphoblastic leukaemia (ALL) can be treated safely with significantly less intensive chemotherapy.

NHS eye gene therapy restores Saffie's sight

Saffie has had her sight restored thanks to life-changing eye gene therapy for rare blindness at GOSH

£3M study led by patient voices targets pain in inflammatory arthritis

A new £3 million research programme involving Great Ormond Street Hospital and University College London researchers aims to tackle one of the largest unmet clinical needs in inflammatory arthritis – pain reduction.